FABP1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, a previous study provided evidence that increased serum L-FABP levels indicated ongoing liver damage in patients with NAFLD and showed relationships between L-FABP and BMI, glucose, AST, ALT, and γ-glutamyltransferase.